동물용 CRO 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Veterinary CRO Market - Scope of Report

TMR's report on the global veterinary CRO market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global veterinary CRO market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global veterinary CRO market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the veterinary CRO market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global veterinary CRO market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global veterinary CRO market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary CRO market.

The report delves into the competitive landscape of the global veterinary CRO market. Key players operating in the global veterinary CRO market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global veterinary CRO market profiled in this report.

Key Questions Answered in Global veterinary CRO market Report:

• What is the sales/revenue generated by veterinary CRO across all regions during the forecast period?
• What are the opportunities in the global veterinary CRO market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Veterinary CRO Market - Research Objectives and Research Approach

The comprehensive report on the global veterinary CRO market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global veterinary CRO market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global veterinary CRO market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Veterinary CRO Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Veterinary CRO Market Analysis and Forecasts, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

• 5.1. List of Leading Veterinary CROs across Key Regions / Countries
• 5.2. Regulatory Scenario across Key Regions / Countries
• 5.3. PORTER's Five Forces Analysis
• 5.4. PESTEL Analysis
• 5.5. Value Chain Analysis
• 5.6. Key Purchase Metrics for End-users
• 5.7. Go-to-Market Strategy for New Market Entrants
• 5.8. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
• 5.9. Benchmarking of the Services Offered by the Leading Competitors

6. Global Veterinary CRO Market Analysis and Forecasts, By Service Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Service Type, 2020-2035
  • 6.3.1. Clinical Trial Services
  • 6.3.2. Market Authorization and Regulatory Support
  • 6.3.3. Toxicology Services
  • 6.3.4. Pharmacokinetic Services
  • 6.3.5. Laboratory Pathology Services
  • 6.3.6. Others
• 6.4. Market Attractiveness By Service Type

7. Global Veterinary CRO Market Analysis and Forecasts, By Animal Type

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Animal Type, 2020-2035
  • 7.3.1. Companion Animals
    • 7.3.1.1. Dogs
    • 7.3.1.2. Cats
    • 7.3.1.3. Others
  • 7.3.2. Livestock Animals
    • 7.3.2.1. Cattle
    • 7.3.2.2. Pigs
    • 7.3.2.3. Sheep & Goat
    • 7.3.2.4. Others
• 7.4. Market Attractiveness By Animal Type

8. Global Veterinary CRO Market Analysis and Forecasts, By Therapeutic Area

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Therapeutic Area, 2020-2035
  • 8.3.1. Infectious Diseases
  • 8.3.2. Orthopedic Disorders
  • 8.3.3. Gastrointestinal Disorders
  • 8.3.4. Dermatology
  • 8.3.5. Oncology
  • 8.3.6. Others
• 8.4. Market Attractiveness By Therapeutic Area

9. Global Veterinary CRO Market Analysis and Forecasts, By Region

• 9.1. Key Findings
• 9.2. Market Value Forecast By Region
  • 9.2.1. North America
  • 9.2.2. Europe
  • 9.2.3. Asia Pacific
  • 9.2.4. Latin America
  • 9.2.5. Middle East & Africa
• 9.3. Market Attractiveness By Region

10. North America Veterinary CRO Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Key Findings
• 10.2. Market Value Forecast By Service Type, 2020-2035
  • 10.2.1. Clinical Trial Services
  • 10.2.2. Market Authorization and Regulatory Support
  • 10.2.3. Toxicology Services
  • 10.2.4. Pharmacokinetic Services
  • 10.2.5. Laboratory Pathology Services
  • 10.2.6. Others
• 10.3. Market Value Forecast By Animal Type, 2020-2035
  • 10.3.1. Companion Animals
    • 10.3.1.1. Dogs
    • 10.3.1.2. Cats
    • 10.3.1.3. Others
  • 10.3.2. Livestock Animals
    • 10.3.2.1. Cattle
    • 10.3.2.2. Pigs
    • 10.3.2.3. Sheep & Goat
    • 10.3.2.4. Others
• 10.4. Market Value Forecast By Therapeutic Area, 2020-2035
  • 10.4.1. Infectious Diseases
  • 10.4.2. Orthopedic Disorders
  • 10.4.3. Gastrointestinal Disorders
  • 10.4.4. Dermatology
  • 10.4.5. Oncology
  • 10.4.6. Others
• 10.5. Market Value Forecast By Country, 2020-2035
  • 10.5.1. U.S.
  • 10.5.2. Canada
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Service Type
  • 10.6.2. By Animal Type
  • 10.6.3. By Therapeutic Area
  • 10.6.4. By Country

11. Europe Veterinary CRO Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Service Type, 2020-2035
  • 11.2.1. Clinical Trial Services
  • 11.2.2. Market Authorization and Regulatory Support
  • 11.2.3. Toxicology Services
  • 11.2.4. Pharmacokinetic Services
  • 11.2.5. Laboratory Pathology Services
  • 11.2.6. Others
• 11.3. Market Value Forecast By Animal Type, 2020-2035
  • 11.3.1. Companion Animals
    • 11.3.1.1. Dogs
    • 11.3.1.2. Cats
    • 11.3.1.3. Others
  • 11.3.2. Livestock Animals
    • 11.3.2.1. Cattle
    • 11.3.2.2. Pigs
    • 11.3.2.3. Sheep & Goat
    • 11.3.2.4. Others
• 11.4. Market Value Forecast By Therapeutic Area, 2020-2035
  • 11.4.1. Infectious Diseases
  • 11.4.2. Orthopedic Disorders
  • 11.4.3. Gastrointestinal Disorders
  • 11.4.4. Dermatology
  • 11.4.5. Oncology
  • 11.4.6. Others
• 11.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 11.5.1. Germany
  • 11.5.2. U.K.
  • 11.5.3. France
  • 11.5.4. Spain
  • 11.5.5. Italy
  • 11.5.6. Rest of Europe
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Service Type
  • 11.6.2. By Animal Type
  • 11.6.3. By Therapeutic Area
  • 11.6.4. By Country / Sub-region

12. Asia Pacific Veterinary CRO Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Service Type, 2020-2035
  • 12.2.1. Clinical Trial Services
  • 12.2.2. Market Authorization and Regulatory Support
  • 12.2.3. Toxicology Services
  • 12.2.4. Pharmacokinetic Services
  • 12.2.5. Laboratory Pathology Services
  • 12.2.6. Others
• 12.3. Market Value Forecast By Animal Type, 2020-2035
  • 12.3.1. Companion Animals
    • 12.3.1.1. Dogs
    • 12.3.1.2. Cats
    • 12.3.1.3. Others
  • 12.3.2. Livestock Animals
    • 12.3.2.1. Cattle
    • 12.3.2.2. Pigs
    • 12.3.2.3. Sheep & Goat
    • 12.3.2.4. Others
• 12.4. Market Value Forecast By Therapeutic Area, 2020-2035
  • 12.4.1. Infectious Diseases
  • 12.4.2. Orthopedic Disorders
  • 12.4.3. Gastrointestinal Disorders
  • 12.4.4. Dermatology
  • 12.4.5. Oncology
  • 12.4.6. Others
• 12.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 12.5.1. China
  • 12.5.2. Japan
  • 12.5.3. India
  • 12.5.4. Australia & New Zealand
  • 12.5.5. Rest of Asia Pacific
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Service Type
  • 12.6.2. By Animal Type
  • 12.6.3. By Therapeutic Area
  • 12.6.4. By Country / Sub-region

13. Latin America Veterinary CRO Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Service Type, 2020-2035
  • 13.2.1. Clinical Trial Services
  • 13.2.2. Market Authorization and Regulatory Support
  • 13.2.3. Toxicology Services
  • 13.2.4. Pharmacokinetic Services
  • 13.2.5. Laboratory Pathology Services
  • 13.2.6. Others
• 13.3. Market Value Forecast By Animal Type, 2020-2035
  • 13.3.1. Companion Animals
    • 13.3.1.1. Dogs
    • 13.3.1.2. Cats
    • 13.3.1.3. Others
  • 13.3.2. Livestock Animals
    • 13.3.2.1. Cattle
    • 13.3.2.2. Pigs
    • 13.3.2.3. Sheep & Goat
    • 13.3.2.4. Others
• 13.4. Market Value Forecast By Therapeutic Area, 2020-2035
  • 13.4.1. Infectious Diseases
  • 13.4.2. Orthopedic Disorders
  • 13.4.3. Gastrointestinal Disorders
  • 13.4.4. Dermatology
  • 13.4.5. Oncology
  • 13.4.6. Others
• 13.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 13.5.1. Brazil
  • 13.5.2. Mexico
  • 13.5.3. Rest of Latin America
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Service Type
  • 13.6.2. By Animal Type
  • 13.6.3. By Therapeutic Area
  • 13.6.4. By Country / Sub-region

14. Middle East & Africa Veterinary CRO Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Service Type, 2020-2035
  • 14.2.1. Clinical Trial Services
  • 14.2.2. Market Authorization and Regulatory Support
  • 14.2.3. Toxicology Services
  • 14.2.4. Pharmacokinetic Services
  • 14.2.5. Laboratory Pathology Services
  • 14.2.6. Others
• 14.3. Market Value Forecast By Animal Type, 2020-2035
  • 14.3.1. Companion Animals
    • 14.3.1.1. Dogs
    • 14.3.1.2. Cats
    • 14.3.1.3. Others
  • 14.3.2. Livestock Animals
    • 14.3.2.1. Cattle
    • 14.3.2.2. Pigs
    • 14.3.2.3. Sheep & Goat
    • 14.3.2.4. Others
• 14.4. Market Value Forecast By Therapeutic Area, 2020-2035
  • 14.4.1. Infectious Diseases
  • 14.4.2. Orthopedic Disorders
  • 14.4.3. Gastrointestinal Disorders
  • 14.4.4. Dermatology
  • 14.4.5. Oncology
  • 14.4.6. Others
• 14.5. Market Value Forecast By Country / Sub-region, 2020-2035
  • 14.5.1. GCC Countries
  • 14.5.2. South Africa
  • 14.5.3. Rest of Middle East & Africa
• 14.6. Market Attractiveness Analysis
  • 14.6.1. By Service Type
  • 14.6.2. By Animal Type
  • 14.6.3. By Therapeutic Area
  • 14.6.4. By Country / Sub-region

15. Competition Landscape

• 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 15.2. Market Share Analysis By Company (2024)
• 15.3. Company Profiles
  • 15.3.1. Charles River Laboratories
    • 15.3.1.1. Company Overview
    • 15.3.1.2. Financial Overview
    • 15.3.1.3. Product Portfolio
    • 15.3.1.4. Business Strategies
    • 15.3.1.5. Recent Developments
  • 15.3.2. IDEXX Laboratories, Inc.
    • 15.3.2.1. Company Overview
    • 15.3.2.2. Financial Overview
    • 15.3.2.3. Product Portfolio
    • 15.3.2.4. Business Strategies
    • 15.3.2.5. Recent Developments
  • 15.3.3. BioAgile Therapeutics Private Limited
    • 15.3.3.1. Company Overview
    • 15.3.3.2. Financial Overview
    • 15.3.3.3. Product Portfolio
    • 15.3.3.4. Business Strategies
    • 15.3.3.5. Recent Developments
  • 15.3.4. Royal GD
    • 15.3.4.1. Company Overview
    • 15.3.4.2. Financial Overview
    • 15.3.4.3. Product Portfolio
    • 15.3.4.4. Business Strategies
    • 15.3.4.5. Recent Developments
  • 15.3.5. KLIFOVET GmbH
    • 15.3.5.1. Company Overview
    • 15.3.5.2. Financial Overview
    • 15.3.5.3. Product Portfolio
    • 15.3.5.4. Business Strategies
    • 15.3.5.5. Recent Developments
  • 15.3.6. Argenta Holdco Limited
    • 15.3.6.1. Company Overview
    • 15.3.6.2. Financial Overview
    • 15.3.6.3. Product Portfolio
    • 15.3.6.4. Business Strategies
    • 15.3.6.5. Recent Developments
  • 15.3.7. Cebiphar
    • 15.3.7.1. Company Overview
    • 15.3.7.2. Financial Overview
    • 15.3.7.3. Product Portfolio
    • 15.3.7.4. Business Strategies
    • 15.3.7.5. Recent Developments
  • 15.3.8. Clinvet
    • 15.3.8.1. Company Overview
    • 15.3.8.2. Financial Overview
    • 15.3.8.3. Product Portfolio
    • 15.3.8.4. Business Strategies
    • 15.3.8.5. Recent Developments
  • 15.3.9. STATKING Clinical Services
    • 15.3.9.1. Company Overview
    • 15.3.9.2. Financial Overview
    • 15.3.9.3. Product Portfolio
    • 15.3.9.4. Business Strategies
    • 15.3.9.5. Recent Developments
  • 15.3.10. OCRvet
    • 15.3.10.1. Company Overview
    • 15.3.10.2. Financial Overview
    • 15.3.10.3. Product Portfolio
    • 15.3.10.4. Business Strategies
    • 15.3.10.5. Recent Developments
  • 15.3.11. LOHLEIN & WOLF VET RESEARCH
    • 15.3.11.1. Company Overview
    • 15.3.11.2. Financial Overview
    • 15.3.11.3. Product Portfolio
    • 15.3.11.4. Business Strategies
    • 15.3.11.5. Recent Developments
  • 15.3.12. VETSPIN SRL
    • 15.3.12.1. Company Overview
    • 15.3.12.2. Financial Overview
    • 15.3.12.3. Product Portfolio
    • 15.3.12.4. Business Strategies
    • 15.3.12.5. Recent Developments
  • 15.3.13. Inotiv
    • 15.3.13.1. Company Overview
    • 15.3.13.2. Financial Overview
    • 15.3.13.3. Product Portfolio
    • 15.3.13.4. Business Strategies
    • 15.3.13.5. Recent Developments
  • 15.3.14. Knoell
    • 15.3.14.1. Company Overview
    • 15.3.14.2. Financial Overview
    • 15.3.14.3. Product Portfolio
    • 15.3.14.4. Business Strategies
    • 15.3.14.5. Recent Developments
  • 15.3.15. Cloudbyz
    • 15.3.15.1. Company Overview
    • 15.3.15.2. Financial Overview
    • 15.3.15.3. Product Portfolio
    • 15.3.15.4. Business Strategies
    • 15.3.15.5. Recent Developments